Ann: SMX Collaboration agreement with BASF, page-100

Quanta you are right.

- The chart is looking exceptional
- We have just made an agreement with a $103B tier 1 company to trial our technology
- We have multiple other stage 2/3 trials which Co has indicated will go to commercialisation when completed
- We have a patented, low capex business idea with multi-industry disruption potential
- We have an excellent Cap structure, tight float and sticky holders

Everything lines up with SMX, We have a very good story to tell and if the tech works well and is commercialised then this is potentially one of the biggest ROI spec end stocks on the ASX I have seen in years. I’m holding LT and accumulating the dips.

DYOR and GLTA